Olmetec 10mg tablets

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Active ingredient:

Olmesartan medoxomil

Available from:

Daiichi Sankyo UK Ltd

ATC code:

C09CA08

INN (International Name):

Olmesartan medoxomil

Dosage:

10mg

Pharmaceutical form:

Oral tablet

Administration route:

Oral

Class:

No Controlled Drug Status

Prescription type:

Valid as a prescribable product

Product summary:

BNF: 02050502; GTIN: 5015494280109

Patient Information leaflet

OLMETEC
® 10 MG TABLETS
OLMESARTAN MEDOXOMIL 10MG TABLETS
OLMETEC
® 40 MG TABLETS
OLMESARTAN MEDOXOMIL 40MG TABLETS
(olmesartan medoxomil)
PATIENT INFORMATION LEAFLET
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE
BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU.
- Keep this leaflet. You may need to read it again.
- If you have any further questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you only. Do not pass it on to
others. It
may harm them, even if their signs of illness are the same as yours.
- If you get any side effects, talk to your doctor or pharmacist. This
includes any
possible side effects not listed in this leaflet. See Section 4.
Your medicine is known by the above names but will be referred to as
Olmetec throughout this leaflet.
WHAT IS IN THIS LEAFLET
1. What Olmetec is and what it is used for
2. What you need to know before you take Olmetec
3. How to take Olmetec
4. Possible side effects
5. How to store Olmetec
6. Contents of the pack and other information
1. WHAT OLMETEC IS AND WHAT IT IS USED FOR
Olmetec belongs to a group of medicines called angiotensin-II receptor
antagonists. They lower blood pressure by relaxing the blood vessels.
Olmetec is used for the treatment of high blood pressure (also known
as
‘hypertension’) in adults and in children and adolescents aged 6
to less
than 18 years. High blood pressure can damage blood vessels in organs
such as the heart, kidneys, brain and eyes. In some cases, this may
lead to
a heart attack, heart or kidney failure, stroke or blindness. Usually
high
blood pressure has no symptoms. It is important to have your blood
pressure checked to prevent damage occurring.
High blood pressure can be controlled with medicines such as Olmetec
tablets. Your doctor has probably also recommended that you make some
changes in your lifestyle to help lower your blood pressure (for
example
losing weight, giving up smoking, reducing the amount of alcohol you
drink
and reducing the amount of salt in your diet)

Summary of Product characteristics

OBJECT 1
OLMETEC FILM-COATED TABLETS
Summary of Product Characteristics Updated 04-Oct-2017 | Daiichi
Sankyo UK Limited
1. Name of the medicinal product
Olmetec 10 mg film-coated tablets
Olmetec 20 mg film-coated tablets
Olmetec 40 mg film-coated tablets
2. Qualitative and quantitative composition
Olmesartan medoxomil
Each film-coated tablet contains 10 mg olmesartan medoxomil
Each film-coated tablet contains 20 mg olmesartan medoxomil
Each film-coated tablet contains 40 mg olmesartan medoxomil
Excipient with known effect
Olmetec 10 mg film-coated tablets: each film-coated tablet contains
61.6 mg lactose monohydrate
Olmetec 20 mg film-coated tablets: each film-coated tablet contains
123.2 mg lactose monohydrate
Olmetec 40 mg film-coated tablets: each film-coated tablet contains
246.4 mg lactose monohydrate
For the full list of excipients, see section 6.1
3. Pharmaceutical form
Film-coated tablet.
Olmetec 10 and 20 mg tablets: White, circular, film-coated tablets
with C13 and C14 respectively
embossed on one side.
Olmetec 40 mg tablets: White, oval, film-coated tablets with C15
embossed on one side.
4. Clinical particulars
4.1 Therapeutic indications
Treatment of essential hypertension in adults.
Treatment of hypertension in children and adolescents from 6 to less
than 18 years of age.
4.2 Posology and method of administration
Posology
_Adults_
The recommended starting dose of olmesartan medoxomil is 10 mg once
daily. In patients whose blood
pressure is not adequately controlled at this dose, the dose of
olmesartan medoxomil may be increased to
20 mg once daily as the optimal dose. If additional blood pressure
reduction is required, olmesartan
medoxomil dose may be increased to a maximum of 40 mg daily or
hydrochlorothiazide therapy may be
added_. _
The antihypertensive effect of olmesartan medoxomil is substantially
present within 2 weeks of initiating
therapy and is maximal by about 8 weeks after initiating therapy. This
should be borne in mind when
considering changing the dose regimen for any patient.
_Elderly